Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

Giuseppe Di Lorenzo^*, Riccardo Autorino, Sisto Perdonà, Michele De Laurentiis, Massimo D'Armiento, Giuseppe Cancello, Vincenzo Mirone, Ciro Imbimbo, Nicola Longo, Vincenzo Altieri, Gianpaolo Tortora, William D. Figg, Sabino De Placido

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review